Registered Members    Remember credentials •  Establish the EU at the forefront of global xenotransplantation research, a field with huge potential for the treatment of end-stage organ failure. At the end of the programme, the project aims to deliver a European “product” for xenotransplantation.   •  Generate in vivo efficacy data and provide experimental evidence that “engineered” pigs, combined with new immunosuppressive reagents, allow long-term survival of porcine organs transplanted in non human primates.   •  Assess new immunosuppressive regimens and agents for efficient inhibition of immunological rejection. Gain an understanding of the physiology of long-term transplanted xenografts in primate recipients.   •  Establish the necessary safety framework to allow progression of xenotransplantation to the clinic   •  Provide a strong ethical, social, educational through direct engagement of the public) and regulatory framework for Xenotransplantation.